What Researchers Did
Researchers observed 409 patients with severe necrotizing soft tissue infections in Scandinavia to understand how hyperbaric oxygen therapy was used as an additional treatment.
What They Found
Out of 409 patients with necrotizing soft tissue infections, 402 (98.3%) were admitted to the ICU. Most patients, 329, received hyperbaric oxygen therapy, with the first treatment typically given 4.3 hours after arriving at a specialized hospital. Patients who received hyperbaric oxygen therapy generally had less severe underlying conditions and lower illness severity scores.
What This Means for Canadian Patients
This study helps understand how hyperbaric oxygen therapy is used for severe necrotizing soft tissue infections. For Canadian patients with these life-threatening infections, this research highlights that hyperbaric oxygen therapy is often given, but patient stability and access to treatment facilities can influence its use. It suggests that timely access to this therapy might be important for those who can receive it.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study acknowledges potential selection bias because not all severely ill patients could receive hyperbaric oxygen therapy due to their condition or treatment availability.